Episode Mentions
Mad Money w/ Jim Cramer · Jul 10, 2026
Mad Money w/ Jim Cramer 7/10/26
“Biotech example of secular growth; stock traded under $5 in 2005, grew into pharmaceutical powerhouse with $10B+ annual sales”
Individual Stock Picking vs. Index FundsSecular Growth Stock InvestingPortfolio Construction (50/50 Index/Individual Split)
View Analysis
Squawk Pod · Apr 24, 2026
David Sacks, Anthropic, & the White House, Regeneron’s Deafness Cure 4/24/26
“FDA approved Otarmony gene therapy for genetic deafness; offering treatment free to U.S. patients; negotiated drug pricing deal with Trump administration”
AI Chip Demand and Semiconductor SupplyGovernment AI Procurement and Use RestrictionsAI Model Bias and Political Alignment
View Analysis
Pharma and BioTech Daily · Apr 24, 2026
Regeneron Gene Therapy Approved by FDA: A Game-Changer! | Pharma and Biotech Daily
“Achieved FDA approval for Otarmini, a gene therapy for hearing loss, using the National Priority Voucher Program”
Gene Therapy Regulation and FDA Approval PathwaysHearing Loss Treatment InnovationGLP-1 Receptor Agonists for Type 2 Diabetes
View Analysis